Abstract:Mitochondrial dysfunction and excessive inflammatory responses are both sufficient to induce pathology in age-dependent neurodegenerations. However, emerging evidence indicates crosstalk between damaged mitochondrial and inflammatory signaling can exacerbate issues in chronic neurodegenerations. This review discusses evidence for the interaction between mitochondrial damage and inflammation, with a focus on glaucomatous neurodegeneration, and proposes that positive feedback resulting from this crosstalk drives pathology. Mitochondrial dysfunction exacerbates inflammatory signaling in multiple ways. Damaged mitochondrial DNA is a damage-associated molecular pattern, which activates the NLRP3 inflammasome; priming and activation of the NLRP3 inflammasome, and the resulting liberation of IL-1β and IL-18 via the gasdermin D pore, is a major pathway to enhance inflammatory responses. The rise in reactive oxygen species induced by mitochondrial damage also activates inflammatory pathways, while blockage of Complex enzymes is sufficient to increase inflammatory signaling. Impaired mitophagy contributes to inflammation as the inability to turnover mitochondria in a timely manner increases levels of ROS and damaged mtDNA, with the latter likely to stimulate the cGAS-STING pathway to increase interferon signaling. Mitochondrial associated ER membrane contacts and the mitochondria-associated adaptor molecule MAVS can activate NLRP3 inflammasome signaling. In addition to dysfunctional mitochondria increasing inflammation, the corollary also occurs, with inflammation reducing mitochondrial function and ATP production; the resulting downward spiral accelerates degeneration. Evidence from several preclinical models including the DBA/2J mouse, microbead injection and transient elevation of IOP, in addition to patient data, implicates both mitochondrial damage and inflammation in glaucomatous neurodegeneration. The pressure-dependent hypoxia and the resulting metabolic vulnerability is associated with mitochondrial damage and IL-1β release. Links between mitochondrial dysfunction and inflammation can occur in retinal ganglion cells, microglia cells and astrocytes. In summary, crosstalk between damaged mitochondria and increased inflammatory signaling enhances pathology in glaucomatous neurodegeneration, with implications for other complex age-dependent neurodegenerations like Alzheimer's and Parkinson's disease.

Relationship Between Mitochondrial Dysfunction and Glaucoma

Mitochondrial dysfunction in glaucomatous degeneration

The Role of Mitochondrial Dysfunction in Hereditary Optic Neuropathy

Deregulation of Mitochondrial Fusion and Fission in Neurodegenerative Diseases

Mitochondrial functional defects and the disorders in the nervous system

Mitochondria in Retinal Ganglion Cells: Unraveling the Metabolic Nexus and Oxidative Stress

Demyelination of the Optic Nerve: An Underlying Factor in Glaucoma?

Crosstalk Between Dysfunctional Mitochondria and Inflammation in Glaucomatous Neurodegeneration

The potential for mitochondrial therapeutics in the treatment of primary open-angle glaucoma: a review

Mitochondrial Dysfunction in Neural Injury

Association between glaucoma susceptibility with combined defects in mitochondrial oxidative phosphorylation and fatty acid beta oxidation

[The role of mitochondrial dysfunction in the stabilization of the glaucomatous process]

Research Progress on Mitochondrial Dysfunction in Diabetic Retinopathy

The mechanisms of natural products for eye disorders by targeting mitochondrial dysfunction

Cumulative Mtdna Damage and Mutations Contribute to the Progressive Loss of RGCs in a Rat Model of Glaucoma.

Pathological Interplay between Inflammation and Mitochondria Aggravates Glutamate Toxicity

Mitochondrial dysfunction as a therapeutic strategy for neurodegenerative diseases: Current Insights and Future Directions

Mitophagy: An Emerging Target in Ocular Pathology

Changes of Mitochondrial Dynamics Related Genes Expression in a Glaucoma Rat Model

Mitochondrial dysfunction in microglia: a novel perspective for pathogenesis of Alzheimer's disease

Targeting Mitochondrial Dysfunction and Oxidative Stress to Prevent the Neurodegeneration of Retinal Ganglion Cells